Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Recruiting 4

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Carcinoma, Non-Small-Cell Lung 23Breast Neoplasms 22Prostatic Neoplasms 21Glioblastoma 19Lung Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Rectal Neoplasms 12Glioma 12Neoplasms 11Oropharyngeal Neoplasms 10Head and Neck Neoplasms 10Esophageal Neoplasms 8Astrocytoma 8Sarcoma 7Neoplasm Metastasis 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Esophageal Squamous Cell Carcinoma 6Colorectal Neoplasms 6Carcinoma, Squamous Cell 6Brain Neoplasms 6Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Lymphoma, Follicular 5Hodgkin Disease 5Gliosarcoma 5Carcinoma, Hepatocellular 5Carcinoma 5Burkitt Lymphoma 5

Interventions

Cisplatin 18Gemcitabine 14Radiotherapy, Intensity-Modulated 11Magnetic Resonance Spectroscopy 8toripalimab 7Specimen Handling 7Capecitabine 7Platinum 5Drug Therapy 51,2-diaminocyclohexaneplatinum II citrate 5camrelizumab 4Radiotherapy 4Nivolumab 4spartalizumab 3sintilimab 3anlotinib 3Immunoglobulin G 3Immune Checkpoint Inhibitors 3Docetaxel 3Disulfides 3atezolizumab 2Radiation 2Phantoms, Imaging 2Ipilimumab 2Carboplatin 2CTLA-4 Antigen 2Biopsy 2Bevacizumab 218-O-demethylcervinomycin A2 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × Radiotherapy × 90 days × Clear all
NCT06064097 2026-06-03

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

National Cancer Institute (NCI)

Phase 2 Recruiting
50 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Sun Yat-sen University

Phase 3 Recruiting
380 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT06323239 2026-05-11

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Recruiting
148 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07201337 2026-04-06

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Sun Yat-sen University

Phase 3 Recruiting
700 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡